NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00171873,Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut,https://clinicaltrials.gov/study/NCT00171873,,COMPLETED,Placebo-controlled prospective randomized phase III study to investigate the antiproliferative effect of octreotide in patients with metastasized neuroendocrine tumors of the midgut,YES,Neuroendocrine Tumors,DRUG: Octreotide LAR (Long-acting release)|DRUG: Placebo,"Time to Tumor Progression Documented by Computed Tomography (CT) or Magnetic Resonance Imaging (MRI), Median time to tumor progression at the time of the planned interim analysis that includes all data observed until June 2008., Up to 7 years","Objective Response Rates According to World Health Organization (WHO) Criteria at 3 Month Intervals, at 3 month intervals|Biochemical Response at 3 Month Intervals, at 3 month intervals up to 18 moths|Symptom Control at 3 Month Intervals, at 3 month intervals up to 18 moths|Quality of Life (Standardized Questionnaire) at Three-month Intervals in Comparison With the Start of the Study, at three-month intervals|Survival, at least on a monthly basis",,Carmen Schade-Brittinger,,ALL,"ADULT, OLDER_ADULT",PHASE3,85,OTHER,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",CSMS995ADE05,2001-09,2008-06,2013-12,2005-09-15,2011-03-28,2020-03-26,"Novartis Investigative Site, Bochum, Germany|Novartis Investigative Site, Dresden, Germany|Novartis Investigative Site, Halle, Germany|Novartis Investigative Site, Hamburg, Germany|Novartis Investigative Site, Kiel, Germany|Novartis Investigative Site, Leipzig, Germany|Novartis Investigative Site, Mainz, Germany|Novartis Investigative Site, Marburg, 35033, Germany|Novartis Investigative Site, Marburg, Germany|Novartis Investigative Site, Munchen, Germany",
